Ohgushi Hajime, Miyake Jun, Tateishi Tetsuya
Tissue Engineering Research Center (TERC), National Institute of Advanced Industrial Science and Technology (AIST), 3-11-46 Nakouji, Amagasaki City, Hyogo 661-0794, Japan.
Novartis Found Symp. 2003;249:118-27; discussion 127-32, 170-4, 239-41.
Bone is formed by cells called osteoblasts, which arise from mesenchymal stem cells (MSCs). The cells are known to exist in thin tissues surrounding bone (periosteum) and bone marrow, but the population is extremely small. The number of marrow-derived MSCs can be expanded using tissue culture techniques. These culture-expanded MSCs have the in vitro capacity to differentiate into osteoblasts. Importantly, the cultured osteoblasts can form extracellular matrix in culture. This matrix consists of fine crystals of hydroxyapatite comparable to natural bone mineral, as evidenced by X-ray diffraction and Fourier-transform infrared spectroscopy. It is possible to fabricate the osteoblasts/ bone matrix on the surface of bioceramics. Thus in vitro cultured bone can show further bone-forming capability after in vivo implantation. We have begun studying this tissue-engineering approach in patients with skeletal problems. This paper describes this and other approaches using MSCs to regenerate skeletal tissue.
骨由称为成骨细胞的细胞形成,而成骨细胞源自间充质干细胞(MSC)。已知这些细胞存在于骨周围的薄组织(骨膜)和骨髓中,但数量极少。骨髓来源的间充质干细胞数量可以通过组织培养技术进行扩增。这些培养扩增的间充质干细胞在体外具有分化为成骨细胞的能力。重要的是,培养的成骨细胞可以在培养物中形成细胞外基质。通过X射线衍射和傅里叶变换红外光谱证明,这种基质由与天然骨矿物质相当的羟基磷灰石细晶体组成。可以在生物陶瓷表面制备成骨细胞/骨基质。因此,体外培养的骨在体内植入后可以显示出进一步的骨形成能力。我们已经开始在患有骨骼问题的患者中研究这种组织工程方法。本文描述了这种以及其他使用间充质干细胞再生骨骼组织的方法。